Flux Peptides
$0.00 0

Cart

No products in the cart.

BPC-157 research peptide vial
Three BPC-157 research peptide vials

BPC-157

$50.00

BPC-157 (Body Protection Compound 157) is a synthetic pentadecapeptide, a chain of 15 amino acids corresponding to a partial sequence of a protein found in human gastric juice. Published work on BPC-157 is preclinical (cell culture and rodent models) and has examined angiogenesis signalling, collagen synthesis and interaction with the nitric oxide system.

  • Fast Domestic Shipping: Dispatched from within Canada (no customs delays)
  • Purity: ≥99.0% (HPLC tested)
  • Format: Lyophilized powder for laboratory research
  • Key Research Focus: Angiogenesis signalling and collagen synthesis in laboratory models
  • Storage: Store at minus 20 degrees Celsius, sealed and protected from light and moisture
SKU: FLX-BPC157-10MG Category:

Description

BPC-157 (Body Protection Compound 157)

BPC-157 is a synthetic pentadecapeptide whose sequence corresponds to a fragment of a protein identified in human gastric juice. It is not an approved medicine in Canada or the United States. In regulatory records it appears only among bulk substances nominated for pharmacy compounding, and the material supplied here is a research chemical.

The published literature on BPC-157 consists of in vitro work and rodent studies. Reported observations centre on growth factor receptor expression, angiogenesis and collagen organisation. These are findings in cell and animal models and have not been established in controlled human trials.

Technical Specifications

  • Peptide Name: BPC-157
  • Sequence: Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val
  • CAS Number: 137525-51-0
  • Molecular Formula: C62H98N16O22
  • Molar Mass: 1419.5 g/mol
  • Purity: ≥99.0% (determined by HPLC)
  • Appearance: White lyophilized powder
  • Solubility: Soluble in sterile water

Research Context

Pathways that have been examined in the published literature include:

  • VEGF expression and angiogenesis: BPC-157 was associated with increased vascular endothelial growth factor (VEGF) expression and new capillary formation in rodent and cell culture models.
  • Collagen organisation: In vitro and rodent studies have examined its association with type I collagen synthesis and fibre arrangement.
  • Nitric oxide system: BPC-157 has been studied in the nitric oxide pathway in rodent models, including experiments using NO synthase inhibitors and NO donors.
  • Fibroblast behaviour: Cell culture studies have examined fibroblast migration and proliferation after exposure to BPC-157.

These are observations in laboratory models and should not be read as describing effects in a person or an animal outside a controlled study.

Storage and Handling

  • Lyophilized (powder): Store at minus 20 degrees Celsius, sealed and protected from light and moisture; see the batch documentation for the retest date.
  • Reconstituted (liquid): Keep refrigerated at 4 degrees Celsius and protected from light. The retest date in the batch documentation applies to the sealed lyophilized vial only.
  • Handling: Standard laboratory safety protocols apply. This product is for laboratory research use only.

Testing and Quality Control
Every vial of BPC-157 is released against the following checks:

1. HPLC (high-performance liquid chromatography): to confirm a purity profile of ≥99.0%.
2. MS (mass spectrometry): to confirm the molecular weight and identity of the peptide.
3. Visual verification: to confirm the integrity of the lyophilized cake.

For laboratory research use only. Not for human or veterinary use.

Further reading